Peroxisome proliferator-activated receptor-γligands inhibit nuclear but not cytosolic extracellular signal-regulated kinase/mitogen-activated protein kinase-regulated steps in vascular smooth muscle cell migration

Journal of Cardiovascular Pharmacology

Volumn 38, Issue 6, 2001, Pages 909-921

  Goetze, Stephan ^a,b   Kintscher, Ulrich ^a,b   Kim, Sarah ^b   Meehan, Woerner P ^b   Kaneshiro, Kristina ^b   Collins, Alan R ^b   Fleck, Eckart ^a   Hsueh, Willa A ^b   Law, Ronald E ^b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Restenosis; Signal transduction; Smooth muscle

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MYOSIN LIGHT CHAIN KINASE; MYOSIN LIGHT CHAIN KINASE INHIBITOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA LIGAND; ROSIGLITAZONE; TRANSCRIPTION FACTOR ETS 1; TROGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; AORTA; ARTERY INJURY; ARTICLE; CELL ADHESION; CELL INVASION; CELL MIGRATION; CELL MOTION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME INDUCTION; ENZYME PHOSPHORYLATION; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTIC DISEASES; CELL ADHESION; CELL MOVEMENT; CELL NUCLEUS; CELLS, CULTURED; CHROMANS; CYTOSOL; ENZYME INHIBITORS; GRAFT OCCLUSION, VASCULAR; LIGANDS; MALE; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE, SMOOTH, VASCULAR; PROTO-ONCOGENE PROTEIN C-ETS-1; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-ETS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; THIAZOLIDINEDIONES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS;

EID: 0035201123     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200112000-00013     Document Type: Article

References (44)

1. The pathogenesis of atherosclerosis: A perspective for the 1990s
2. Perspectives series: Cell adhesion in vascular biology: Smooth muscle migration in atherosclerosis and restenosis
3. Mitogen-activated protein kinase activation is involved in platelet-derived growth factor-directed migration by vascular smooth muscle cells
4. TNFα-induced migration of vascular smooth muscle cells is MAPK-dependent
5. Central role of the MAPK pathway in AII-mediated DNA-synthesis and migration in rat vascular smooth muscle cells
6. Smooth muscle cell migration and proliferation are mediated by distinct phases of activation of the intracellular messenger mitogen-activated protein kinase
7. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner
8. Regulation of cell motility by mitogen-activated protein kinase
9. Phosphorylation of myosin light chain kinase by the multifunctional calmodulin-dependent protein kinase II in smooth muscle cells
10. Regulation of vascular smooth muscle cell migration by mitogen-activated protein kinase and calcium/calmodulin-dependent protein kinase II signaling pathways
11. Regulation of endothelial cell myosin light chain kinase by Rho, cortactin and p60 src
12. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation
13. Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor
14. PPARgamma ligands inhibit migration mediated by multiple chemoattractants in vascular smooth muscle cells
15. Troglitazone inhibits angiotensin II-induced DNA synthesis and migration in vascular smooth muscle cells
16. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells
17. Expression and function of PPARgamma in rat and human vascular smooth muscle cells
18. Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in rat aortic smooth muscle cells
19. Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro
20. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells
21. Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells
22. Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury
23. The Ets-1 and Ets-2 transcription factors activated the promoters for invasion-associated urokinase and collagenase genes in response to EGF
24. Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides
25. Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia
26. The smooth muscle cell in culture
27. Blood pressure lowering by pioglitazone. Evidence for a direct vascular effect
28. Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR
29. Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery
30. Interdomain communication regulating ligand binding by PPAR-gamma
31. Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase
32. Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of PPARgamma
33. Blockade of the MAPK pathway suppresses growth of colon tumors in vivo
34. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor
35. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
36. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway
37. Kinetics of cellular proliferation after arterial injury: I: Smooth muscle growth in the absence of endothelium
38. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NFkappaB and AP-1
39. Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene
40. Modulating nuclear receptor function: May the phos be with you
41. Vasculo-protective effects of insulin sensitizing agent pioglitazone in neointimal thickening and hypertensive vascular hypertrophy
42. Pioglitazone reduces smooth muscle cell density of rat carotid arterial intima induced by balloon catheterization
43. PPAR-gamma dependent and independent effects on macrophage gene expression in lipid metabolism and inflammation
44. Troglitazone reduces intimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: A serial intravascular ultrasound study